Jérémy Picard
Jérémy Picard has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Anne Coste
Service de Maladies Infectieuses Et Tropicales, Centre Hospitalier Et Universitaire de Brest, Brest, France.
2 shared publications - Clémence Beauruelle
Département de Bactériologie-Virologie, Hygiène et Parasitologie-Mycologie, Centre Hospitalier Régional Universitaire (CHRU) de Brest, Brest, France
2 shared publications - Geneviève Héry-Arnaud
Univ Brest, INSERM, EFS, UMR 1078, GGB - Brest France; Brest Center for Microbiota Analysis (CBAM), Brest University Hospital - Brest France; Department of Infectious Agents, Brest University Hospital - Brest France
2 shared publications Nicolas Galakhoff
2 shared publicationsRaoul Baron
2 shared publicationsAurore Trameçon
1 shared publication
Latest Publications
- Open Access
- 21 September 2026
- Published by Elsevier in Infection Prevention in Practice
- Vol. 8 (4)
Prevention of carbapenemase-producing Enterobacterales outbreaks: evaluation of a simplified contact screening policy
- 21 September 2026
- Published by Elsevier in Infection Prevention in Practice
- Vol. 8 (4)
Open AccessPrevention of carbapenemase-producing Enterobacterales outbreaks: evaluation of a simplified contact screening policy
- Open Access
Is Metagenomics the Future Routine Diagnosis Tool for Brain Abscesses? About a Case
Shotgun metagenomics (SMg) usefulness for brain abscess diagnosis is not known. We describe a case of brain abscess diagnosed with SMg and provide a review of the literature. A 70-year-old woman was diagnosed with multiple brain abscesses. Standard culture techniques and 16S rRNA gene sequencing of abscess samples remained negative. SMg finally revealed the presence of sequences from Streptococcus anginosus and Fusobacterium nucleatum, leading to antimicrobial treatment adaptation and corticosteroids initiation. The patient finally recovered. A literature review retrieved fifteen other cases of brain abscesses diagnosed with SMg. SMg results led to changes in patient management in most cases. The existing literature about the performances of SMg, its advantages, future evolutions, and limitations is then discussed. SMg place in routine should be evaluated and defined through prospective studies.
Open AccessIs Metagenomics the Future Routine Diagnosis Tool for Brain Abscesses? About a Case
Shotgun metagenomics (SMg) usefulness for brain abscess diagnosis is not known. We describe a case of brain abscess diagnosed with SMg and provide a review of the literature. A 70-year-old woman was diagnosed with multiple brain abscesses. Standard culture techniques and 16S rRNA gene sequencing of abscess samples remained negative. SMg finally revealed the presence of sequences from Streptococcus anginosus and Fusobacterium nucleatum, leading to antimicrobial treatment adaptation and corticosteroids initiation. The patient finally recovered. A literature review retrieved fifteen other cases of brain abscesses diagnosed with SMg. SMg results led to changes in patient management in most cases. The existing literature about the performances of SMg, its advantages, future evolutions, and limitations is then discussed. SMg place in routine should be evaluated and defined through prospective studies.
- 2 August 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 45 (1) , 27-34
Comorbidities directly extracted from the hospital database for adjusting SSI risk in the new national semiautomated surveillance system in France: The SPICMI network
Objective:To evaluate the performance of a comorbidity-based risk-adjustment model for surgical-site infection (SSI) reporting and benchmarking using a panel of variables extracted from the hospital discharge database (HDD), including comorbidities, compared to other models that use variables from different data sources.Methods:The French national surveillance program for SSI (SPICMI) has collected data from voluntary hospitals in the first 6 months of 2020 and 2021, for 16 selected surgery procedures, using a semiautomated algorithm for detection. Four risk-adjustment models were selected with logistic regression analysis, combining the different patterns of variables: National Nosocomial Infections Surveillance System (NNIS) risk-index components, individual operative data, and 6 individual comorbidities according to International Classification of Disease, Tenth Revision (ICD-10) diagnosis: obesity, diabetes, malnutrition, hypertension, cancer, or immunosuppression. Areas under the curve (AUCs) were calculated and compared.Results:Overall, 294 SSI were detected among 11,975 procedures included. All 6 comorbidities were related to SSI in the univariate analysis. The AUC of the selected model including comorbidities (0.675; 95% confidence interval [CI], 0.642–0.707), was significantly higher than the AUC of the model without comorbidities (0.641; 95% CI, 0.609–0.672; P = .016) or the AUC using the NNIS-index components (0.598; 95% CI, 0.564–0.630; P < .001). The HDD-based model AUC (0.659; 95% CI, 0.625–0.692) did not differ significantly from the selected model without comorbidities (P = .23).Conclusion:Including HDD-based comorbidities as patient case-mix variables instead of NNIS risk index factors could be an effective approach for risk-adjustment of automated SSI surveillance more widely accessible to hospitals.
- 2 August 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 45 (1) , 27-34
Comorbidities directly extracted from the hospital database for adjusting SSI risk in the new national semiautomated surveillance system in France: The SPICMI network
Objective:To evaluate the performance of a comorbidity-based risk-adjustment model for surgical-site infection (SSI) reporting and benchmarking using a panel of variables extracted from the hospital discharge database (HDD), including comorbidities, compared to other models that use variables from different data sources.Methods:The French national surveillance program for SSI (SPICMI) has collected data from voluntary hospitals in the first 6 months of 2020 and 2021, for 16 selected surgery procedures, using a semiautomated algorithm for detection. Four risk-adjustment models were selected with logistic regression analysis, combining the different patterns of variables: National Nosocomial Infections Surveillance System (NNIS) risk-index components, individual operative data, and 6 individual comorbidities according to International Classification of Disease, Tenth Revision (ICD-10) diagnosis: obesity, diabetes, malnutrition, hypertension, cancer, or immunosuppression. Areas under the curve (AUCs) were calculated and compared.Results:Overall, 294 SSI were detected among 11,975 procedures included. All 6 comorbidities were related to SSI in the univariate analysis. The AUC of the selected model including comorbidities (0.675; 95% confidence interval [CI], 0.642–0.707), was significantly higher than the AUC of the model without comorbidities (0.641; 95% CI, 0.609–0.672; P = .016) or the AUC using the NNIS-index components (0.598; 95% CI, 0.564–0.630; P < .001). The HDD-based model AUC (0.659; 95% CI, 0.625–0.692) did not differ significantly from the selected model without comorbidities (P = .23).Conclusion:Including HDD-based comorbidities as patient case-mix variables instead of NNIS risk index factors could be an effective approach for risk-adjustment of automated SSI surveillance more widely accessible to hospitals.